ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Dragonfly Therapeutics Adds Natural Killer Cell-Based Cancer Immunotherapy Expert to Its Scientific – PR Newswire (press release)

Dragonfly Therapeutics Adds Natural Killer Cell-Based Cancer Immunotherapy Expert to Its ScientificPR Newswire (press release)Dragonfly Therapeutics Adds Natural Killer Cell-Based Cancer Immunotherapy Expert to Its Scientific Advisory Board. Dr. Adelhe… Continue reading

2017-05-23 Michael Zand NEWS

Oncolytics Biotech® Inc. Announces Participation in World Immunotherapy Congress USA 2017 – PR Newswire (press release)

Continue reading

2017-05-23 Michael Zand NEWS

US Stem Cell Inc (OTCMKTS:USRM) HEFFX Highlights – Live Trading News

Live Trading NewsUS Stem Cell Inc (OTCMKTS:USRM) HEFFX HighlightsLive Trading NewsU.S. Stem Cell, Inc., formerly Bioheart, Inc., is a biotechnology company. The Company is focused on the discovery, development and, subject to regulatory approval, comme… Continue reading

2017-05-23 Michael Zand NEWS

Stem cell treatments ready to replace medicine in 10 years: Expert – Jakarta Post

Jakarta PostStem cell treatments ready to replace medicine in 10 years: ExpertJakarta PostStem cells can be obtained from umbilical cord blood that is kept in a stem cell bank, back bone marrow and fat. However, fat and bone marrow will decline in qual… Continue reading

2017-05-23 Michael Zand NEWS

Stem cell treatments ready to replace medicine in 10 years: Expert – Jakarta Post

Jakarta PostStem cell treatments ready to replace medicine in 10 years: ExpertJakarta PostStem cells can be obtained from umbilical cord blood that is kept in a stem cell bank, back bone marrow and fat. However, fat and bone marrow will decline in qual… Continue reading

2017-05-23 Michael Zand NEWS

BRIEF-Hansa Medical: preclinical results confirm IdeS potential in cancer immunotherapy – Reuters

Oncolytics Biotech® Inc. Announces Participation in World Immunotherapy Congress USA 2017
PR Newswire (press release)
CALGARY, May 23, 2017 /PRNewswire/ – Oncolytics Biotech Inc. (TSX:ONC) (OTCQX:ONCYF) (Oncolytics or the Company) today announced that Dr. Andres A. Gutierrez, Chief Medical Officer of Oncolytics Biotech Inc. will present at the World Immunotherapy …

and more »

Continue reading

2017-05-23 Michael Zand NEWS

How the CRISPR-Cas9 System is Redefining Drug Discovery – Labiotech.eu (blog)

BRIEF-Hansa Medical: preclinical results confirm IdeS potential in cancer immunotherapy
Reuters
Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world’s largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news …

and more »

Continue reading

2017-05-23 Michael Zand NEWS

How the CRISPR-Cas9 System is Redefining Drug Discovery – Labiotech.eu (blog)


The Cerbat Gem

How the CRISPR-Cas9 System is Redefining Drug Discovery
Labiotech.eu (blog)
“The targets we’re finding with CRISPR-Cas9 are going to guide the drugs coming out in the 2020s,” said Jon Moore, CSO of Horizon Discovery, at a recent event in the UK. Only shortly after the first publication on the new genome engineering system in …
Rodger Novak Sells 616 Shares of Crispr Therapeutics AG (CRSP) StockThe Cerbat Gem
Why GM mosquitoes might not work against malariaFuturity: Research News
Gene Drive’s Achilles HeelThe Scientist
Sports Perspectives –BangaloreWeekly –Financial Times
all 17 news articles »
Continue reading

2017-05-23 Michael Zand NEWS
  • 1
  • …
  • 1,698
  • 1,699
  • 1,700
  • 1,701
  • 1,702
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Labiotech.eu (blog)

How the CRISPR-Cas9 System is Redefining Drug Discovery
Labiotech.eu (blog)
“The targets we’re finding with CRISPR-Cas9 are going to guide the drugs coming out in the 2020s,” said Jon Moore, CSO of Horizon Discovery, at a recent event in the UK. Only shortly after the first publication on the new genome engineering system in …
Rodger Novak Sells 616 Shares of Crispr Therapeutics AG (CRSP) StockThe Cerbat Gem
Insects Can Resist Genetic Methods to Control Disease SpreadR & D Magazine
Gene Drive’s Achilles HeelThe Scientist
Sports Perspectives –BangaloreWeekly –Financial Times
all 21 news articles »